» Authors » Yoshikazu Nakano

Yoshikazu Nakano

Explore the profile of Yoshikazu Nakano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 335
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakano Y, Hirano S, Tamura M, Koizumi Y, Kitayama Y, Izumi M, et al.
Sci Rep . 2025 Mar; 15(1):8056. PMID: 40055432
Rigidity, a cardinal symptom of Parkinson's disease (PD), remains challenging to assess objectively. A torque-angle instrument was developed to quantify muscle tone, providing two parameters: bias difference and elastic coefficient....
2.
Tang C, Nakano Y, Vo A, Nguyen N, Schindlbeck K, Mattis P, et al.
Nat Commun . 2024 Dec; 15(1):10797. PMID: 39737936
Isolated rapid eye movement sleep behavior disorder is a prodrome of α-synucleinopathies. Using positron emission tomography, we assessed changes in Parkinson's disease-related motor and cognitive metabolic networks and caudate/putamen dopaminergic...
3.
Eidelberg D, Tang C, Nakano Y, Vo A, Nguyen N, Schindlbeck K, et al.
Res Sq . 2024 Jun; PMID: 38853923
Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal syndrome for Parkinson's disease (PD) and related -synucleinopathies. We conducted a longitudinal imaging study of network changes in iRBD...
4.
Nakano Y, Shimada H, Shinotoh H, Hirano S, Tagai K, Sano Y, et al.
Parkinsonism Relat Disord . 2022 May; 98:92-98. PMID: 35533530
Introduction: Corticobasal degeneration (CBD) is the most common neuropathological substrate for clinically diagnosed corticobasal syndrome (CBS), while identifying CBD pathology in living individuals has been challenging. This study aimed to...
5.
Nakano Y, Hirano S, Kojima K, Li H, Sakurai T, Suzuki M, et al.
Mov Disord . 2022 Mar; 37(6):1235-1244. PMID: 35285050
Background: Cerebral blood flow (CBF) and dopamine transporter (DAT) images are clinically used for the differential diagnosis of parkinsonian disorders. Objectives: This study aimed to examine the correlation of CBF...
6.
Hashimoto M, Nakano Y, Tamura Y
Surg Case Rep . 2021 Apr; 7(1):106. PMID: 33913037
Background: Diastolic retrograde flow in the descending aorta (DAo) may occur in the presence of atherosclerosis and may be overlooked as a mechanism of retrograde embolization in patients with stroke....
7.
Sawai S, Mori M, Makino T, Nakano Y, Kuwabara S, Kamitsukasa I
eNeurologicalSci . 2021 Mar; 23:100335. PMID: 33763606
Hiccups, nausea and vomiting are known as the clinical manifestations of neuromyelitis optica spectrum disorder (NMOSD) linked to lesions of the area postraema in the medullary tegmentum. Here, we describe...
8.
Sakurai T, Hirano S, Abe M, Uji Y, Shimizu K, Suzuki M, et al.
Amyotroph Lateral Scler Frontotemporal Degener . 2020 Dec; 22(3-4):267-275. PMID: 33331163
Language dysfunction is a feature of cognitive impairment in amyotrophic lateral sclerosis (ALS) that may compromise communication. To elucidate language dysfunction in patients with ALS and its relationship with other...
9.
Chishiki Y, Hirano S, Li H, Kojima K, Nakano Y, Sakurai T, et al.
Cogn Behav Neurol . 2020 Dec; 33(4):253-258. PMID: 33264152
Background: Individuals with early-onset Alzheimer disease (EOAD) differ from those with late-onset Alzheimer disease (LOAD) not only in genetics and age at onset but also in their clinical symptoms. Objective:...
10.
Tai H, Hirano S, Sakurai T, Nakano Y, Ishikawa A, Kojima K, et al.
J Alzheimers Dis . 2020 Nov; 78(4):1639-1652. PMID: 33185599
Background: Neuropsychological tests, structural neuroimaging, and functional neuroimaging are employed as diagnostic and monitoring biomarkers of patients with Alzheimer's disease (AD)Objective:We aimed to elucidate the similarities and differences in neuropsychological...